title: Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits.
abstract: The activation of the sympathetic nervous system through the central actions of the adipokine leptin has been suggested as a major mechanism by which obesity contributes to the development of hypertension. However, direct evidence for elevated sympathetic activity in obesity has been limited to muscle. The present study examined the renal sympathetic nerve activity and cardiovascular effects of a high-fat diet (HFD), as well as the changes in the sensitivity to intracerebroventricular leptin. New Zealand white rabbits fed a 13.5% HFD for 4 weeks showed modest weight gain but a 2- to 3-fold greater accumulation of visceral fat compared with control rabbits. Mean arterial pressure, heart rate, and plasma norepinephrine concentration increased by 8%, 26%, and 87%, respectively (P<0.05), after 3 weeks of HFD. Renal sympathetic nerve activity was 48% higher (P<0.05) in HFD compared with control diet rabbits and was correlated to plasma leptin (r=0.87; P<0.01). Intracerebroventricular leptin administration (5 to 100 microg) increased mean arterial pressure similarly in both groups, but renal sympathetic nerve activity increased more in HFD-fed rabbits. By contrast, intracerebroventricular leptin produced less neurons expressing c-Fos in HFD compared with control rabbits in regions important for appetite and sympathetic actions of leptin (arcuate: -54%, paraventricular: -69%, and dorsomedial hypothalamus: -65%). These results suggest that visceral fat accumulation through consumption of a HFD leads to marked sympathetic activation, which is related to increased responsiveness to central sympathoexcitatory effects of leptin. The paradoxical reduction in hypothalamic neuronal activation by leptin suggests a marked "selective leptin resistance" in these animals.
authors.affiliation: Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria 8008, Australia.
authors.forename: Larissa J
authors.initials: LJ
authors.lastname: Prior
authors.forename: Nina
authors.initials: N
authors.lastname: Eikelis
authors.forename: James A
authors.initials: JA
authors.lastname: Armitage
authors.forename: Pamela J
authors.initials: PJ
authors.lastname: Davern
authors.forename: Sandra L
authors.initials: SL
authors.lastname: Burke
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Montani
authors.forename: Benjamin
authors.initials: B
authors.lastname: Barzel
authors.forename: Geoffrey A
authors.initials: GA
authors.lastname: Head
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D001835:Body Weight / Q000502:physiology; D002408:Catheters, Indwelling; D004041:Dietary Fats / Q000378:metabolism* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D007031:Hypothalamus / Q000378:metabolism; D007276:Injections, Intraventricular; D050152:Intra-Abdominal Fat / Q000378:metabolism; D007668:Kidney / Q000294:innervation*; D020738:Leptin / Q000008:administration & dosage / Q000378:metabolism*; D008297:Male; D009474:Neurons / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D011817:Rabbits; D054411:Receptors, Leptin / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism*
chemical_list: D004041:Dietary Fats; D020738:Leptin; D016760:Proto-Oncogene Proteins c-fos; D054411:Receptors, Leptin